Mesa Laboratories, Inc.

NasdaqGS:MLAB Stock Report

Market Cap: US$722.7m

Mesa Laboratories Management

Management criteria checks 2/4

Mesa Laboratories' CEO is Gary Owens, appointed in Sep 2017, has a tenure of 7.25 years. total yearly compensation is $5.44M, comprised of 13.9% salary and 86.1% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth $5.77M. The average tenure of the management team and the board of directors is 7.3 years and 4.6 years respectively.

Key information

Gary Owens

Chief executive officer

US$5.4m

Total compensation

CEO salary percentage13.9%
CEO tenure7.3yrs
CEO ownership0.8%
Management average tenure7.3yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

Mesa Laboratories: GKE Acquisition New Crown Jewel, Still Doesn't Move The Needle

Dec 19

Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

Nov 20
Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Oct 17
We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Jul 29
A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

May 03
Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mar 15
Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08
Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Dec 05
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Sep 28
Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Aug 09
Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Jun 28
We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

May 31
Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Apr 12
A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Mar 13
Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Dec 20
Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Mesa Laboratories declares $0.16 dividend

Oct 03

Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced

Sep 09

Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?

Sep 06
Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?

Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Aug 08
Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M

Aug 04

Mesa Laboratories declares $0.16 dividend

Jul 07

CEO Compensation Analysis

How has Gary Owens's remuneration changed compared to Mesa Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$246m

Jun 30 2024n/an/a

-US$250m

Mar 31 2024US$5mUS$754k

-US$254m

Dec 31 2023n/an/a

US$948k

Sep 30 2023n/an/a

-US$717k

Jun 30 2023n/an/a

US$2m

Mar 31 2023US$5mUS$733k

US$930k

Dec 31 2022n/an/a

-US$1m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022US$18mUS$579k

US$2m

Dec 31 2021n/an/a

US$8m

Sep 30 2021n/an/a

US$5m

Jun 30 2021n/an/a

US$4m

Mar 31 2021US$3mUS$524k

US$3m

Dec 31 2020n/an/a

-US$2m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020US$3mUS$600k

US$2m

Dec 31 2019n/an/a

US$5m

Sep 30 2019n/an/a

US$10m

Jun 30 2019n/an/a

US$8m

Mar 31 2019US$3mUS$520k

US$7m

Dec 31 2018n/an/a

US$10m

Sep 30 2018n/an/a

-US$2m

Jun 30 2018n/an/a

-US$249k

Mar 31 2018US$1mUS$417k

-US$3m

Compensation vs Market: Gary's total compensation ($USD5.44M) is above average for companies of similar size in the US market ($USD3.21M).

Compensation vs Earnings: Gary's compensation has increased whilst the company is unprofitable.

CEO

Gary Owens (56 yo)

7.3yrs

Tenure

US$5,435,566

Compensation

Mr. Gary M. Owens has been Chief Executive Officer, President and Director of Mesa Laboratories, Inc. since September 1, 2017. Mr. Owens joined as Chief Operating Officer in March 2017. Mr. Owens served as...

Leadership Team

NamePositionTenureCompensationOwnership
Gary Owens
CEO, President & Director7.3yrsUS$5.44m0.80%
$ 5.8m
John Sakys
VP, CFO & Chief Accounting Officer12.2yrsUS$1.94m0.22%
$ 1.6m
Brian Archbold
Senior Vice President of Continuous Improvement6.9yrsUS$1.62m0%
$ 0

7.3yrs

Average Tenure

55yo

Average Age

Experienced Management: MLAB's management team is seasoned and experienced (7.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gary Owens
CEO, President & Director7.3yrsUS$5.44m0.80%
$ 5.8m
Shiraz Ladiwala
Lead Independent Director3.2yrsUS$220.03k0.057%
$ 409.1k
John Sullivan
Independent Chairman of the Board15.8yrsUS$255.13k1.3%
$ 9.4m
R. Tripeny
Independent Director2.5yrsUS$220.13k0.049%
$ 356.4k
Mark Capone
Independent Directorless than a yearUS$90.03k0.013%
$ 96.3k
Shannon Hall
Independent Director4.6yrsUS$220.13k0.051%
$ 370.6k
Jennifer Alltoft
Independent Director5.8yrsUS$220.13k0.064%
$ 462.2k

4.6yrs

Average Tenure

58yo

Average Age

Experienced Board: MLAB's board of directors are considered experienced (4.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 00:26
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mesa Laboratories, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vijay KumarEvercore ISI
Paul KnightJanney Montgomery Scott LLC
Tycho PetersonJefferies LLC